Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B

Institute of Immunology, PLA, Third Military Medical University, Chongqing 400038, PR China, 1Department of Dermatology, the 181th Hospital of PLA, Guilin 541002, PR China, 2Systems Biology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA, 3Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA, 4Department of Infectious Diseases, Southwestern Hospital, Third Military Medical University, Chongqing 400038, PR China and 5van Velkinburgh Initiative for Collaboratory BioMedical Research, Santa Fe, NM 87501, USA